Pharmaceutical HOLDRS (AMEX: PPH) ended the last trading session at $58.71. So far PPH has hit a 52-week low of $49.28 and 52-week high of $72.49. PPH has been showing support around 56.97 and resistance in the 59.59 range. Technical indicators are Bullish. PPH appears on the Investors Observer Select ETF and HOLDR list. For a hedged play on this stock, look at a Nov '09 55 covered call (PPH KK) for a net debit in the $53.31 area. That is also the break even stock price for this trade. This covered call has a 173 day duration, provides 9.20% downside protection and a 3.17% assigned return rate for a 6.69% annualized return rate (comparison purposes only). A lower cost hedged play for this stock would use a longer term call option in place of the covered call stock purchase. To use this strategy look at going long the PPH Jan '10 45 Call (WIG AI) and selling the Nov '09 55 call (PPH KK) for an $8.50 debit. The trade has a 173 day life and would provide 8.87% downside protection and a 17.65% assigned return rate for a 37.00% annualized return rate
Subscribe to:
Post Comments (Atom)
Superhit News
-
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing fac...
-
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharma...
-
Rib-X Pharmaceuticals, Inc. announced today the signature of an exclusive worldwide research collaboration agreement and option for license ...
-
Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groupsPhysiomics ( LON:PYC ) said that trading conditions were difficult in the six months ended 31 December 2010, but it believes it is in a be...
-
Hindusthan National Glass and Industries Ltd is expected to finalize a strategic overseas acquisition in the pharmaceuticals space in the n...
-
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about th...
-
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one y...
-
India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after...
-
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name ...
-
Amylin Pharmaceuticals, Inc. AMLN +16.15% and Alkermes plc ALKS +4.61% today announced that the U.S. Food and Drug Administration (FDA) has ...
No comments:
Post a Comment